Acrux Limited (ACR) Earnings Call Transcripts
Acrux Limited's Latest Earnings Call - Q1 FY2026
In the first quarter of 2026, Axactor ASA reported gross revenues of EUR 75 million, a decline of 3% year-over-year, primarily due to portfolio sales in Spain and Germany. The company announced a significant EUR 200 million private placement with Fortress, enhancing its financial flexibility and investment capacity. Management provided new financial targets, aiming for annual investments of EUR 200 million to EUR 400 million in NPL portfolios and a return on equity exceeding 15%. Despite the revenue decline, the partnership with Fortress is expected to drive future growth, although collection performance has been challenged by macroeconomic factors.
Reported metrics
| Metric | Value |
|---|---|
| Gross Revenue | EUR 75 million (miss) |
| NPL Revenue | EUR 37 million (miss) |
| 3PC Revenue | EUR 16 million (beat) |
| EBITDA | EUR 22 million (inline) |
| Operating Expenses | 41% of gross revenue (positive) |
| Effective NPL Amortization Rate | 21% (negative) |
Guidance from management
Axactor targets to invest between EUR 200 million and EUR 400 million annually in NPL portfolios and aims for a return on equity exceeding 15%. The company plans to initiate shareholder distributions in June 2027, contingent on refinancing current outstanding bonds.
What analysts pressed on
Analysts expressed concerns regarding the drop in collection performance, questioning the sustainability of the previously positive outlook for 2026. Management acknowledged that expected macroeconomic improvements have not materialized, impacting collection rates significantly.
Main topics on the call
- Private Placement and Fortress Partnership — Axactor announced a transformational EUR 200 million private placement with Fortress, which will acquire a 30% stake in the company. Johnny Vasili stated, "This transaction is vital in creating net profit growth going fo...
- Revenue Decline — The company reported gross revenue of EUR 75 million, down 3% from Q1 2025. CFO Nina Mortensen noted that the decline was mainly due to "portfolio sales in Spain and Germany last year and the low investment level in 2025...
- NPL Segment Performance — The NPL segment generated revenues of EUR 37 million, a decrease from EUR 45 million in Q1 2025, attributed to negative net revaluations of EUR 9 million. The effective NPL amortization rate increased to 21%, up from 17%...
- 3PC Segment Growth — The 3PC segment reported revenues of EUR 16 million, up 5% year-over-year, with an underlying growth of 12% when adjusted for one-off impacts. Management highlighted a "strong underlying momentum across countries" as a d...
Read the full Acrux Limited transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Acrux Limited
Acrux Limited (ACR) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on ASX and is based in AU. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 56 calls on record spanning March 4, 2020 to August 17, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 56 Acrux Limited earnings call transcripts on record, spanning March 4, 2020 to August 17, 2026. Based on this history, Acrux Limited reports quarterly. The most recent call on file is dated August 17, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- ACR
- Exchange
- ASX
- Country
- AU
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 56
- First call
- March 4, 2020
- Most recent
- August 17, 2026
- Reporting cadence
- quarterly